Classics in Chemical Neuroscience: U-47700

Area of Science:

• Chemical Neuroscience
• Medicinal Chemistry
• Pharmacology

Background:

• U-47700, a novel synthetic opioid (NSO), was discovered in the 1970s and exhibits potent in vivo activity, exceeding morphine.
• Its ease of synthesis and limited detection methods have contributed to widespread abuse, appearing in counterfeit drugs and as a component of "gray death."
• U-47700 is now a Schedule I drug globally due to its emergence in illicit markets and association with overdose deaths, including a high-profile case.

Purpose of the Study:

• To provide a comprehensive historical overview of U-47700 spanning over 40 years.
• To detail the synthesis, medicinal chemistry, and in vitro/in vivo pharmacology of U-47700.
• To examine the drug metabolism and societal impact of U-47700, particularly in the context of overdose cases.

Main Methods:

• Literature review of U-47700's history, synthesis, and chemical properties.
• Analysis of pharmacological data regarding in vitro and in vivo activity.
• Examination of postmortem drug metabolism studies and societal impact reports.

Main Results:

• U-47700 possesses significantly higher potency than morphine.
• The drug has become a substance of widespread abuse, necessitating its classification as a controlled substance.
• Its presence has been documented in counterfeit pharmaceuticals and illicit drug mixtures.

Conclusions:

• U-47700 represents a significant challenge in public health and law enforcement due to its potent opioid effects and illicit proliferation.
• Understanding its multifaceted profile is crucial for addressing the ongoing synthetic opioid crisis.
• This review serves as a foundational resource on U-47700, a key compound in chemical neuroscience research and forensic toxicology.